X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5711) 5711
Book Review (760) 760
Publication (445) 445
Book / eBook (41) 41
Magazine Article (39) 39
Book Chapter (12) 12
Conference Proceeding (9) 9
Dissertation (9) 9
Government Document (3) 3
Trade Publication Article (3) 3
Web Resource (3) 3
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5623) 5623
female (5616) 5616
index medicus (5117) 5117
adult (3252) 3252
middle aged (2812) 2812
cervical cancer (2606) 2606
uterine cervical neoplasms - prevention & control (2329) 2329
uterine cervical neoplasms - diagnosis (1908) 1908
cancer (1802) 1802
aged (1616) 1616
women (1454) 1454
uterine cervical neoplasms - epidemiology (1351) 1351
adolescent (1302) 1302
oncology (1241) 1241
socioeconomic factors (1126) 1126
public, environmental & occupational health (1062) 1062
human papillomavirus (1009) 1009
uterine cervical neoplasms - virology (964) 964
diagnosis (958) 958
young adult (901) 901
papillomavirus infections - prevention & control (870) 870
risk factors (841) 841
uterine cervical neoplasms - pathology (811) 811
obstetrics & gynecology (803) 803
health aspects (796) 796
prevention (769) 769
vaginal smears (755) 755
medical screening (751) 751
papanicolaou test (733) 733
cost-benefit analysis (727) 727
research (712) 712
male (703) 703
abridged index medicus (670) 670
papillomavirus infections (600) 600
uterine cervical neoplasms - economics (594) 594
womens health (593) 593
analysis (576) 576
mass screening - economics (572) 572
health knowledge, attitudes, practice (565) 565
vaccination (564) 564
medicine, general & internal (562) 562
mass screening (555) 555
age factors (551) 551
mortality (541) 541
screening (534) 534
risk (531) 531
public health (525) 525
prevalence (498) 498
vaccines (498) 498
united states (477) 477
papillomavirus infections - epidemiology (457) 457
cross-sectional studies (453) 453
mass screening - methods (452) 452
surveys and questionnaires (452) 452
incidence (444) 444
united-states (443) 443
cervical-cancer (426) 426
papillomavirus infections - diagnosis (425) 425
uterine cervical neoplasms - mortality (399) 399
hpv (398) 398
papillomavirus vaccines - economics (397) 397
child (394) 394
infection (393) 393
papillomavirus infections - virology (392) 392
epidemiology (389) 389
papillomavirus vaccines - administration & dosage (388) 388
papillomavirus infections - complications (386) 386
vaginal smears - economics (382) 382
cytology (370) 370
uterine cervical neoplasms - ethnology (369) 369
health (364) 364
care and treatment (360) 360
population (359) 359
aged, 80 and over (354) 354
cervix (352) 352
immunization (351) 351
human-papillomavirus (344) 344
uterine cervical neoplasms - therapy (340) 340
cost-effectiveness (338) 338
retrospective studies (335) 335
research article (330) 330
early detection of cancer (328) 328
breast neoplasms - diagnosis (327) 327
breast (316) 316
uterine cervical neoplasms - etiology (308) 308
papillomaviridae - isolation & purification (292) 292
mammography (291) 291
colposcopy (286) 286
breast cancer (284) 284
breast neoplasms - prevention & control (284) 284
oncology, experimental (284) 284
uterine cervical neoplasms (281) 281
young-women (277) 277
cervical intraepithelial neoplasia - diagnosis (276) 276
immunology (275) 275
obstetrics and gynecology (275) 275
carcinoma (273) 273
neoplasm staging (273) 273
sensitivity and specificity (272) 272
vaginal smears - utilization (272) 272
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5489) 5489
French (66) 66
Spanish (54) 54
Portuguese (46) 46
German (32) 32
Italian (20) 20
Polish (19) 19
Chinese (17) 17
Swedish (14) 14
Danish (11) 11
Dutch (9) 9
Norwegian (8) 8
Russian (8) 8
Bulgarian (7) 7
Hungarian (6) 6
Japanese (6) 6
Czech (3) 3
Finnish (2) 2
Hebrew (2) 2
Romanian (2) 2
Croatian (1) 1
Korean (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 11/2017, Volume 35, Issue 46, pp. 6329 - 6335
Estonia has high cervical cancer incidence and low screening coverage. We modelled the impact of population-based bivalent, quadrivalent or nonavalent HPV... 
Genital warts | Cost-effectiveness | Vaccination | Cervical cancer | HPV | MEDICINE, RESEARCH & EXPERIMENTAL | COUNTRIES | IMMUNOLOGY | WOMEN | TRANSMISSION | MEN | INFECTION | BURDEN | HUMAN-PAPILLOMAVIRUS-VACCINATION | QUADRIVALENT | VACCINES | Estonia - epidemiology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Incidence | Young Adult | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Uterine Cervical Neoplasms - economics | Adult | Female | Anus Neoplasms - epidemiology | Oropharyngeal Neoplasms - economics | Child | Papillomavirus Vaccines - administration & dosage | Mouth Neoplasms - prevention & control | Papillomavirus Infections - complications | Papillomavirus Vaccines - economics | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Mouth Neoplasms - economics | Models, Statistical | Mouth Neoplasms - epidemiology | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Cost-Benefit Analysis | Adolescent | Vaginal Neoplasms - economics | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Aged | Anus Neoplasms - economics | Medical research | Analysis | Medicine, Experimental | Diagnosis | Cancer | Health insurance | Immunization | Sensitivity analysis | Mortality | Vagina | Infections | Vaccines | Cervix | Cost benefit analysis | Medical screening | Immunity | Girls | Cancer vaccines | Warts | Screening | Human papillomavirus | Utilities | Markov models | Lesions | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2016, Volume 108, Issue 1, p. djv282
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 42, pp. 6016 - 6019
Highlights ► We estimated the annual direct medical costs attributable to HPV in the USA. ► The overall annual direct medical cost burden was estimated to be... 
Allergy and Immunology | Genital warts | Human papillomavirus | Health economics | Intraepithelial neoplasia | Cost | Vulvar, vaginal, anal, oral cavity, oropharyngeal, and cervical cancer | MEDICINE, RESEARCH & EXPERIMENTAL | POPULATION | IMMUNOLOGY | US HEALTH PLAN | CANCER SCREENING RATES | IMPACT | RECURRENT RESPIRATORY PAPILLOMATOSIS | HPV VACCINE | BURDEN | BENEFITS | Early Detection of Cancer - economics | United States - epidemiology | Papillomavirus Vaccines - economics | Humans | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - epidemiology | Respiratory Tract Infections - prevention & control | Uterine Cervical Neoplasms - prevention & control | Condylomata Acuminata - epidemiology | Cost of Illness | Respiratory Tract Infections - economics | Condylomata Acuminata - prevention & control | Papillomavirus Infections - economics | Oropharyngeal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Health Care Costs - statistics & numerical data | Uterine Cervical Neoplasms - economics | Condylomata Acuminata - economics | Female | Oropharyngeal Neoplasms - prevention & control | Oropharyngeal Neoplasms - economics | Respiratory Tract Infections - epidemiology | Prevention | Warts | Papillomaviruses | Sexually transmitted diseases | Oncology, Experimental | Research | Papillomavirus infections | Cervical cancer | Cancer | Medical care, Cost of | Vaccines | Medical screening | Womens health | Index Medicus | Economics | Penis | Vaccination | Vagina | Papilloma | oropharyngeal cancer | Anogenital | genital warts | cost | intraepithelial neoplasia | vulvar | anal | oral cavity | vaginal | health economics
Journal Article
Journal Article
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 1, pp. 156 - 167.e4
Abstract Purpose A complete economic evaluation requires accurate data concerning the resources used, outcomes, and utilities (patient’s preferences) to... 
Internal Medicine | Medical Education | CIN 1 | CIN 2–3 | anal cancer | quality of life | utilities | cervical cancer | TTO | anogenital warts | head and neck squamous cell carcinoma | HPV | Utilities | Anogenital warts | Anal cancer | Head and neck squamous cell carcinoma | CIN 2-3 | Cervical cancer | Quality of life | COST | ECONOMIC-EVALUATION | HUMAN-PAPILLOMAVIRUS VACCINATION | BOYS | PHARMACOLOGY & PHARMACY | INFECTION | PREFERENCE | Head and Neck Neoplasms - economics | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Anus Neoplasms - prevention & control | Male | Cervical Intraepithelial Neoplasia - economics | Ethnic Groups | Carcinoma, Squamous Cell - economics | Uterine Cervical Neoplasms - economics | Adult | Female | Papillomavirus Infections - virology | Vaccination - economics | Head and Neck Neoplasms - prevention & control | Papillomavirus Vaccines - economics | Anus Neoplasms - veterinary | Risk Factors | Uterine Cervical Neoplasms - prevention & control | Immunization Programs - economics | Carcinoma, Squamous Cell - prevention & control | Cervical Intraepithelial Neoplasia - virology | Papillomavirus Infections - economics | Papillomavirus Infections - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Quality of Life | Uterine Cervical Neoplasms - virology | Italy | Papillomaviridae | Anus Neoplasms - economics | Health Status | Medical research | Vaccination | Medicine, Experimental | Development and progression | Papillomavirus infections | Health aspects | Risk factors | Studies | Human papillomavirus | Sexually transmitted diseases--STD | Immunization | Vaccines | Index Medicus
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 136, Issue 3, pp. 521 - 528
Abstract Objective To evaluate toxicity and cost-effectiveness of intensity modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Cost-benefit analysis | Uterine cervical neoplasms | Radiotherapy, conformal | Endometrial neoplasms | Radiotherapy, intensity-modulated | Health care economics | ADJUVANT TREATMENT | RANDOMIZED-TRIAL | CERVICAL-CANCER | WHOLE PELVIC RADIOTHERAPY | ENDOMETRIAL CANCER | OBSTETRICS & GYNECOLOGY | ONCOLOGY | CONCURRENT CHEMOTHERAPY | UPFRONT TREATMENT | INTERMEDIATE | MALIGNANCIES | CARCINOMA | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - adverse effects | Utah | Radiotherapy, Intensity-Modulated - economics | Uterine Neoplasms - economics | Aged, 80 and over | Uterine Cervical Neoplasms - economics | Uterine Neoplasms - mortality | Adult | Female | Registries | Uterine Neoplasms - radiotherapy | Retrospective Studies | Radiotherapy, Adjuvant | Uterine Cervical Neoplasms - mortality | Databases, Factual | Quality-Adjusted Life Years | Hospital Costs - statistics & numerical data | Uterine Cervical Neoplasms - radiotherapy | Radiotherapy, Intensity-Modulated - methods | Decision Support Techniques | Postoperative Period | Uterine Cervical Neoplasms - surgery | Radiotherapy, Conformal - economics | Treatment Outcome | Hysterectomy | Uterine Neoplasms - surgery | Cost-Benefit Analysis | Survival Analysis | Radiotherapy, Conformal - adverse effects | Aged | Radiotherapy, Conformal - methods | Care and treatment | Radiotherapy | Cost benefit analysis | Analysis | Radiation | Cancer | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2004, Volume 96, Issue 8, pp. 604 - 615
Journal Article
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 03/2014, Volume 121, Issue 4, pp. 464 - 476
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 04/2019, Volume 153, Issue 1, pp. 92 - 99
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 137, Issue 3, pp. 490 - 496
Abstract Objective To evaluate the cost-effectiveness of bevacizumab in recurrent/persistent and metastatic cervical cancer using recently reported updated... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Antiangiogenesis therapy | Markov model | Cost-effectiveness | Cervical cancer | Bevacizumab | GYNECOLOGIC-ONCOLOGY-GROUP | PLUS IRINOTECAN | NEWLY-DIAGNOSED GLIOBLASTOMA | OVARIAN-CANCER | METASTATIC COLORECTAL-CANCER | CELL CARCINOMA | OBSTETRICS & GYNECOLOGY | PHASE-III TRIAL | BREAST-CANCER | ONCOLOGY | RECURRENT | DOUBLE-BLIND | Drug Costs | Markov Chains | Humans | Uterine Cervical Neoplasms - pathology | Models, Economic | Antibodies, Monoclonal, Humanized - economics | Antineoplastic Combined Chemotherapy Protocols - economics | Angiogenesis Inhibitors - therapeutic use | Uterine Cervical Neoplasms - economics | Angiogenesis Inhibitors - economics | Female | Angiogenesis Inhibitors - adverse effects | Uterine Cervical Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Biosimilar Pharmaceuticals - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Uterine Cervical Neoplasms - drug therapy | Biosimilar Pharmaceuticals - economics | Biosimilar Pharmaceuticals - adverse effects | Randomized Controlled Trials as Topic | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cost-Benefit Analysis | Decision Trees | Neoplasm Staging | Antimitotic agents | Markov processes | Models | Antineoplastic agents | Analysis | Health aspects | Index Medicus
Journal Article